Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMS-247550 and Cisplatin in Head and Neck Cancer
NCT00057850Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jan 2002
- Primary completion
- Jul 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ixabepilone in squamous cell carcinoma of the head and neck (HNSCC), sponsored by National Cancer Institute. Primary endpoint: Recommended Phase II Dose. Started Jan 2002; status: completed.
02
Drugs
ixabepilone
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT00057850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00057850.